Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bestrabacil: a possible target-oriented anticancer agent].

N Ohsawa, Z Yamazaki, T Wagatsuma

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cesarean section and primary pulmonary hypertension: the role of intravenous dexmedetomidine.

    International journal of obstetric anesthesia·2009
    Same author

    Comparison between tube compensation and pressure support ventilation techniques on respiratory mechanics.

    Anaesthesia and intensive care·2003
    Same author

    Body height and weight of patients with childhood onset and adult onset thyrotoxicosis.

    Endocrine journal·2002
    Same author

    Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention.

    BJU international·2002
    Same author

    Pancreatic volume in type 1 and type 2 diabetes mellitus.

    Acta diabetologica·2002
    Same author

    Purification and characterization of a monohalomethane-producing enzyme S-adenosyl-L-methionine: halide ion methyltransferase from a marine microalga, Pavlova pinguis.

    Bioscience, biotechnology, and biochemistry·2002
    Same journal

    [A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Recent Advances in the Treatment of HER2-Altered Solid Tumors].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [BRAF-Mutant Solid Tumor].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    See all related articles

    Bestrabucil, an estradiol-chlorambucil conjugate, selectively targets and accumulates in malignant tumor cells, irrespective of estrogen receptor status. This targeted approach shows potent antitumor effects with reduced toxicity compared to traditional chemotherapy.

    Area of Science:

    • Oncology
    • Pharmacology
    • Drug Development

    Context:

    • Bestrabucil is an estradiol-chlorambucil conjugate initially designed for estrogen receptor-positive breast cancers.
    • Subsequent research revealed a broader tumor-targeting capability independent of estrogen receptors.

    Purpose:

    • To investigate the selective accumulation and antitumor efficacy of bestrabucil in malignant cells and tissues.
    • To compare the anti-tumor effects and toxicities of bestrabucil with chlorambucil.

    Summary:

    • In vitro and in vivo studies demonstrated that bestrabucil selectively accumulates in malignant cells (e.g., 3T3-SV40 transformed) over normal cells (3T3).
    • Oral administration in rats with Walker 256 carcinoma showed significant bestrabucil accumulation in tumor tissues, sparing normal tissues and blood.

    Related Experiment Videos

  • Bestrabucil exhibited antitumor effects with minimal impact on leukocyte counts, unlike chlorambucil which caused significant side effects.
  • Clinical studies confirmed higher bestrabucil concentrations in various human tumor tissues compared to adjacent normal tissues 24 hours post-administration.

    • Impact:

    • Bestrabucil demonstrates promising selective tumor cell affinity, suggesting a potential for targeted cancer therapy with an improved safety profile.
    • The findings support further clinical investigation of bestrabucil as a novel anticancer agent for diverse cancer types.